Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Method Development & Validation, Stability Testing), By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within Immediate
Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends
The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 14.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving the market growth. Analytical testing aids in real-time product quality control as well as helps optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.
For instance, in 2021, over 399,525 clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022, it had increased to over 421,258 studies. A continuation of this trend is expected to have a positive impact on the market in the post-pandemic period. The majority of small and medium-sized pharma companies lack the infrastructure for analytical testing. As a result, outsourcing these operations is the best option as it saves time and money. The patent cliff, primarily for small molecules and biologics, is likely to have a positive impact on the market as it will increase the number of commercial drugs in the pharma market, thus promoting the analytical testing of commercially available generic drugs.
There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children’s National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in disease incidence is expected to improve, drug production, which is likely to drive the demand for analytical services for commercial drugs.
Pharmaceutical Analytical Testing Outsourcing Market Report Highlights
Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends
The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 14.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving the market growth. Analytical testing aids in real-time product quality control as well as helps optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.
For instance, in 2021, over 399,525 clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022, it had increased to over 421,258 studies. A continuation of this trend is expected to have a positive impact on the market in the post-pandemic period. The majority of small and medium-sized pharma companies lack the infrastructure for analytical testing. As a result, outsourcing these operations is the best option as it saves time and money. The patent cliff, primarily for small molecules and biologics, is likely to have a positive impact on the market as it will increase the number of commercial drugs in the pharma market, thus promoting the analytical testing of commercially available generic drugs.
There has been a rise in several diseases post-COVID-19. For instance, according to a report published by Children’s National Hospital- pediatric research and clinical innovations center, a study was performed on 737 youths who were diagnosed with diabetes, and it found an increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes (T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in disease incidence is expected to improve, drug production, which is likely to drive the demand for analytical services for commercial drugs.
Pharmaceutical Analytical Testing Outsourcing Market Report Highlights
- The bioanalytical testing segment is expected to witness the fastest CAGR of 8.9% over the forecast due to the high number of clinical trial registrations and entry of new drug participants into the pharmaceutical market
- The pharmaceutical segment gained the largest revenue share of 47.4% in 2021. The growing demand among pharmaceutical companies to focus on their core competencies is one of the major reasons for the largest segment share
- North America is expected to hold the largest revenue share of 53.7% owing to the presence of a significant number of pharmaceutical companies in the region
- Asia Pacific is anticipated to be the fastest-growing regional market from 2022 to 2030 due to the low-cost service offerings by the third-party service providers in the region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: VARIABLES, TRENDS, AND SCOPE
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Innovation and product development
3.2.1.2 Growing demand for Regulation on safety and quality
3.2.1.3 Rising End-users volume
3.2.1.4 Pricing strategies
3.2.2 Market Restraint Analysis
3.2.2.1 Data insecurity
3.2.2.2 Third-party performance
3.3 Penetration & Growth Prospect Mapping
3.4 Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
CHAPTER 4 COVID-19 IMPACT
4.1.Impact on Pharmaceutical analytical Testing Outsourcing Market
4.2 Impact on other related areas
CHAPTER 5 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: SERVICE SEGMENT ANALYSIS
5.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
5.2 Pharmaceutical Analytical Testing Outsourcing Market: Definition & Scope
5.3 Bioanalytical Testing
5.3.1 Bioanalytical Testing market, 2018 - 2030 (USD Million)
5.3.2 Clinical
5.3.2.1 Clinical market, 2018 - 2030 (USD Million)
5.3.3 Non-clinical
5.3.3.1 non-clinical market, 2018 - 2030 (USD Million)
5.4 Method Development & Validation
5.4.1 Method Development & Validation market, 2018 - 2030 (USD Million)
5.4.2 Extractable & Leachable
5.4.2.1 Extractable & Leachable market, 2018 - 2030 (USD Million)
5.4.3 Impurity Method
5.4.3.1 Impurity Method market, 2018 - 2030 (USD Million)
5.4.4 Technical Consulting
5.4.4.1 Technical Consulting market, 2018 - 2030 (USD Million)
5.4.5 Others
5.4.5.1 Others market, 2018 - 2030 (USD Million)
5.5 Stability Testing
5.5.1 Stability Testing market, 2018 - 2030 (USD Million)
5.5.2 Drug Substance
5.5.2.1 Drug Substance market, 2018 - 2030 (USD Million)
5.5.3 Stability Indicating Method Validation
5.5.3.1 Stability Indicating Method Validation market, 2018 - 2030 (USD Million)
5.5.4 Accelerated Stability Testing
5.5.4.1 Accelerated Stability Testing market, 2018 - 2030 (USD Million)
5.5.5 Photostability Testing
5.5.5.1 Photostability Testing market, 2018 - 2030 (USD Million)
5.5.6 Others
5.5.6.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 6 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: END-USE
6.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
6.2 Pharmaceutical Companies
6.2.1 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
6.3 Biopharmaceutical Companies
6.3.1 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
6.4 Contract Research Organizations
6.4.1 Contract Research Organisations market, 2018 - 2030 (USD Million)
CHAPTER 7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: REGIONAL ANALYSIS
7.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
7.2 North America
7.2.1 North America Pharmaceutical Analytical Testing Outsourcing market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.7 Russia
7.3.7.1 Russia Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.8 Netherlands
7.3.8.1 Netherlands Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.9 Switzerland
7.3.9.1 Switzerland Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.10 Turkey
7.3.10.1 Turkey Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.11 Sweden
7.3.11.1 Sweden Pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.7 Indonesia
7.4.7.1 Indonesia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.8 Malaysia
7.4.8.1 Malaysia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.9 Singapore
7.4.9.1 Singapore pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.10 Thailand
7.4.10.1 Thailand pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.11 Taiwan
7.4.11.1 Taiwan pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.6 Chile
7.5.6.1 chile pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.5 Egypt
7.6.5.1 Egypt pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.6 Israel
7.6.6.1 Israel pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.7 Company Profiles
7.7.1 SGS SA
7.7.1.1 Company overview
7.7.1.2 Financial performance
7.7.1.3 Service benchmarking
7.7.1.4 Strategic Initiatives
7.7.2 Labcorp
7.7.2.1 Company overview
7.7.2.2 Financial Overview
7.7.2.3 Service benchmarking
7.7.2.4 Strategic Initiatives
7.7.3 Eurofins Scientific
7.7.3.1 Company overview
7.7.3.2 Financial performance
7.7.3.3 Service benchmarking
7.7.4 Pace Analytical Services LLC
7.7.4.1 Company overview
7.7.4.2 Financial Overview
7.7.4.3 Service benchmarking
7.7.4.4 Strategic Initiatives
7.7.5 Intertek Group plc
7.7.5.1 Company overview
7.7.5.2 Financial performance
7.7.5.3 Service benchmarking
7.7.5.4 Strategic Initiatives
7.7.6 PPD Inc (Thermo fisher Scietific, Inc.)
7.7.6.1 Company overview
7.7.6.2 Financial Overview
7.7.6.3 Service benchmarking
7.7.6.4 Strategic Initiatives
7.7.7 Wuxi AppTec
7.7.7.1 Company overview
7.7.7.2 Financial Performance
7.7.7.3 Service benchmarking
7.7.7.4 Strategic Initiatives
7.7.8 Boston Analytical
7.7.8.1 Company overview
7.7.8.2 Financial Overview
7.7.8.3 Service benchmarking
7.7.8.4 Strategic initiatives
7.7.9 Charles River Laboratories
7.7.9.1 Company overview
7.7.9.2 Financial performance
7.7.9.3 Service benchmarking
7.7.9.4 Strategic Initiatives
7.7.10 West Pharmaceutical Services, Inc
7.7.10.1 Company overview
7.7.10.2 Financial performance
7.7.10.3 Service benchmarking
7.7.10.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: VARIABLES, TRENDS, AND SCOPE
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Innovation and product development
3.2.1.2 Growing demand for Regulation on safety and quality
3.2.1.3 Rising End-users volume
3.2.1.4 Pricing strategies
3.2.2 Market Restraint Analysis
3.2.2.1 Data insecurity
3.2.2.2 Third-party performance
3.3 Penetration & Growth Prospect Mapping
3.4 Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
3.4.3 Major Deals & Strategic Alliances Analysis
CHAPTER 4 COVID-19 IMPACT
4.1.Impact on Pharmaceutical analytical Testing Outsourcing Market
4.2 Impact on other related areas
CHAPTER 5 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: SERVICE SEGMENT ANALYSIS
5.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
5.2 Pharmaceutical Analytical Testing Outsourcing Market: Definition & Scope
5.3 Bioanalytical Testing
5.3.1 Bioanalytical Testing market, 2018 - 2030 (USD Million)
5.3.2 Clinical
5.3.2.1 Clinical market, 2018 - 2030 (USD Million)
5.3.3 Non-clinical
5.3.3.1 non-clinical market, 2018 - 2030 (USD Million)
5.4 Method Development & Validation
5.4.1 Method Development & Validation market, 2018 - 2030 (USD Million)
5.4.2 Extractable & Leachable
5.4.2.1 Extractable & Leachable market, 2018 - 2030 (USD Million)
5.4.3 Impurity Method
5.4.3.1 Impurity Method market, 2018 - 2030 (USD Million)
5.4.4 Technical Consulting
5.4.4.1 Technical Consulting market, 2018 - 2030 (USD Million)
5.4.5 Others
5.4.5.1 Others market, 2018 - 2030 (USD Million)
5.5 Stability Testing
5.5.1 Stability Testing market, 2018 - 2030 (USD Million)
5.5.2 Drug Substance
5.5.2.1 Drug Substance market, 2018 - 2030 (USD Million)
5.5.3 Stability Indicating Method Validation
5.5.3.1 Stability Indicating Method Validation market, 2018 - 2030 (USD Million)
5.5.4 Accelerated Stability Testing
5.5.4.1 Accelerated Stability Testing market, 2018 - 2030 (USD Million)
5.5.5 Photostability Testing
5.5.5.1 Photostability Testing market, 2018 - 2030 (USD Million)
5.5.6 Others
5.5.6.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 6 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: END-USE
6.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
6.2 Pharmaceutical Companies
6.2.1 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
6.3 Biopharmaceutical Companies
6.3.1 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
6.4 Contract Research Organizations
6.4.1 Contract Research Organisations market, 2018 - 2030 (USD Million)
CHAPTER 7 PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: REGIONAL ANALYSIS
7.1 Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2021 & 2030
7.2 North America
7.2.1 North America Pharmaceutical Analytical Testing Outsourcing market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.7 Russia
7.3.7.1 Russia Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.8 Netherlands
7.3.8.1 Netherlands Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.9 Switzerland
7.3.9.1 Switzerland Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.10 Turkey
7.3.10.1 Turkey Pharmaceutical Analytical Testing Outsourcing Market, 2018 - 2030 (USD Million)
7.3.11 Sweden
7.3.11.1 Sweden Pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.7 Indonesia
7.4.7.1 Indonesia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.8 Malaysia
7.4.8.1 Malaysia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.9 Singapore
7.4.9.1 Singapore pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.10 Thailand
7.4.10.1 Thailand pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.4.11 Taiwan
7.4.11.1 Taiwan pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.5.6 Chile
7.5.6.1 chile pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.5 Egypt
7.6.5.1 Egypt pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.6.6 Israel
7.6.6.1 Israel pharmaceutical analytical testing outsourcing market, 2018 - 2030 (USD Million)
7.7 Company Profiles
7.7.1 SGS SA
7.7.1.1 Company overview
7.7.1.2 Financial performance
7.7.1.3 Service benchmarking
7.7.1.4 Strategic Initiatives
7.7.2 Labcorp
7.7.2.1 Company overview
7.7.2.2 Financial Overview
7.7.2.3 Service benchmarking
7.7.2.4 Strategic Initiatives
7.7.3 Eurofins Scientific
7.7.3.1 Company overview
7.7.3.2 Financial performance
7.7.3.3 Service benchmarking
7.7.4 Pace Analytical Services LLC
7.7.4.1 Company overview
7.7.4.2 Financial Overview
7.7.4.3 Service benchmarking
7.7.4.4 Strategic Initiatives
7.7.5 Intertek Group plc
7.7.5.1 Company overview
7.7.5.2 Financial performance
7.7.5.3 Service benchmarking
7.7.5.4 Strategic Initiatives
7.7.6 PPD Inc (Thermo fisher Scietific, Inc.)
7.7.6.1 Company overview
7.7.6.2 Financial Overview
7.7.6.3 Service benchmarking
7.7.6.4 Strategic Initiatives
7.7.7 Wuxi AppTec
7.7.7.1 Company overview
7.7.7.2 Financial Performance
7.7.7.3 Service benchmarking
7.7.7.4 Strategic Initiatives
7.7.8 Boston Analytical
7.7.8.1 Company overview
7.7.8.2 Financial Overview
7.7.8.3 Service benchmarking
7.7.8.4 Strategic initiatives
7.7.9 Charles River Laboratories
7.7.9.1 Company overview
7.7.9.2 Financial performance
7.7.9.3 Service benchmarking
7.7.9.4 Strategic Initiatives
7.7.10 West Pharmaceutical Services, Inc
7.7.10.1 Company overview
7.7.10.2 Financial performance
7.7.10.3 Service benchmarking
7.7.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Pharmaceutical analytical testing outsourcing market snapshot (2021)
Fig. 8 Pharmaceutical analytical testing outsourcing market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Global pharmaceutical R&D spending, 2008 - 2022 (USD billion)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by a factor (political & legal, economic, and technological)
Fig. 15 Heat map analysis
Fig. 16 Pharmaceutical analytical testing outsourcing market service outlook: Segment dashboard
Fig. 17 Pharmaceutical analytical testing outsourcing market: Service movement analysis
Fig. 18 Bioanalytical testing market, 2018 - 2030 (USD Million)
Fig. 19 Clinical market, 2018 - 2030 (USD Million)
Fig. 20 Non-clinical market, 2018 - 2030 (USD Million)
Fig. 21 Method development & validation market, 2018 - 2030 (USD Million)
Fig. 22 Extractable & leachable market, 2018 - 2030 (USD Million)
Fig. 23 Impurity method market, 2018 - 2030 (USD Million)
Fig. 24 Technical consulting market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Stability testing market, 2018 - 2030 (USD Million)
Fig. 27 Drug substance market, 2018 - 2030 (USD Million)
Fig. 28 Stability indicating method validation market, 2018 - 2030 (USD Million)
Fig. 29 Accelerated stability testing market, 2018 - 2030 (USD Million)
Fig. 30 Photostability testing market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Pharmaceutical analytical testing outsourcing market end-use outlook: Segment dashboard
Fig. 33 Pharmaceutical analytical testing outsourcing market: End-use movement analysis
Fig. 34 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 35 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 36 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 37 Regional market: Key takeaways
Fig. 38 Regional outlook, 2021 & 2030
Fig. 39 North America market, 2018 - 2030 (USD Million)
Fig. 40 U.S. market, 2018 - 2030 (USD Million)
Fig. 41 Canada market, 2018 - 2030 (USD Million)
Fig. 42 Europe market, 2018 - 2030 (USD Million)
Fig. 43 Germany market, 2018 - 2030 (USD Million)
Fig. 44 U.K. market, 2018 - 2030 (USD Million)
Fig. 45 France market, 2018 - 2030 (USD Million)
Fig. 46 Italy market, 2018 - 2030 (USD Million)
Fig. 47 Spain market, 2018 - 2030 (USD Million)
Fig. 48 Russia market, 2018 - 2030 (USD Million)
Fig. 49 Netherlands market, 2018 - 2030 (USD Million)
Fig. 50 Switzerland market, 2018 - 2030 (USD Million)
Fig. 51 Turkey market, 2018 - 2030 (USD Million)
Fig. 52 Sweden market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 54 China market, 2018 - 2030 (USD Million)
Fig. 55 Japan market, 2018 - 2030 (USD Million)
Fig. 56 India market, 2018 - 2030 (USD Million)
Fig. 57 Australia market, 2018 - 2030 (USD Million)
Fig. 58 South Korea market, 2018 - 2030 (USD Million)
Fig. 59 Indonesia market, 2018 - 2030 (USD Million)
Fig. 60 Malaysia market, 2018 - 2030 (USD Million)
Fig. 61 Singapore market, 2018 - 2030 (USD Million)
Fig. 62 Thailand market, 2018 - 2030 (USD Million)
Fig. 63 Taiwan market, 2018 - 2030 (USD Million)
Fig. 64 Latin America market, 2018 - 2030 (USD Million)
Fig. 65 Brazil market, 2018 - 2030 (USD Million)
Fig. 66 Mexico market, 2021 - 2030 (USD Million)
Fig. 67 Argentina market, 2018 - 2030 (USD Million)
Fig. 68 Colombia market, 2018 - 2030 (USD Million)
Fig. 69 Chile market, 2018 - 2030 (USD Million)
Fig. 70 MEA market, 2018 - 2030 (USD Million)
Fig. 71 South Africa market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 73 UAE market, 2018 - 2030 (USD Million)
Fig. 74 Egypt market, 2018 - 2030 (USD Million)
Fig. 75 Israel market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Pharmaceutical analytical testing outsourcing market snapshot (2021)
Fig. 8 Pharmaceutical analytical testing outsourcing market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Global pharmaceutical R&D spending, 2008 - 2022 (USD billion)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by a factor (political & legal, economic, and technological)
Fig. 15 Heat map analysis
Fig. 16 Pharmaceutical analytical testing outsourcing market service outlook: Segment dashboard
Fig. 17 Pharmaceutical analytical testing outsourcing market: Service movement analysis
Fig. 18 Bioanalytical testing market, 2018 - 2030 (USD Million)
Fig. 19 Clinical market, 2018 - 2030 (USD Million)
Fig. 20 Non-clinical market, 2018 - 2030 (USD Million)
Fig. 21 Method development & validation market, 2018 - 2030 (USD Million)
Fig. 22 Extractable & leachable market, 2018 - 2030 (USD Million)
Fig. 23 Impurity method market, 2018 - 2030 (USD Million)
Fig. 24 Technical consulting market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Stability testing market, 2018 - 2030 (USD Million)
Fig. 27 Drug substance market, 2018 - 2030 (USD Million)
Fig. 28 Stability indicating method validation market, 2018 - 2030 (USD Million)
Fig. 29 Accelerated stability testing market, 2018 - 2030 (USD Million)
Fig. 30 Photostability testing market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Pharmaceutical analytical testing outsourcing market end-use outlook: Segment dashboard
Fig. 33 Pharmaceutical analytical testing outsourcing market: End-use movement analysis
Fig. 34 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 35 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 36 Contract research organizations market, 2018 - 2030 (USD Million)
Fig. 37 Regional market: Key takeaways
Fig. 38 Regional outlook, 2021 & 2030
Fig. 39 North America market, 2018 - 2030 (USD Million)
Fig. 40 U.S. market, 2018 - 2030 (USD Million)
Fig. 41 Canada market, 2018 - 2030 (USD Million)
Fig. 42 Europe market, 2018 - 2030 (USD Million)
Fig. 43 Germany market, 2018 - 2030 (USD Million)
Fig. 44 U.K. market, 2018 - 2030 (USD Million)
Fig. 45 France market, 2018 - 2030 (USD Million)
Fig. 46 Italy market, 2018 - 2030 (USD Million)
Fig. 47 Spain market, 2018 - 2030 (USD Million)
Fig. 48 Russia market, 2018 - 2030 (USD Million)
Fig. 49 Netherlands market, 2018 - 2030 (USD Million)
Fig. 50 Switzerland market, 2018 - 2030 (USD Million)
Fig. 51 Turkey market, 2018 - 2030 (USD Million)
Fig. 52 Sweden market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 54 China market, 2018 - 2030 (USD Million)
Fig. 55 Japan market, 2018 - 2030 (USD Million)
Fig. 56 India market, 2018 - 2030 (USD Million)
Fig. 57 Australia market, 2018 - 2030 (USD Million)
Fig. 58 South Korea market, 2018 - 2030 (USD Million)
Fig. 59 Indonesia market, 2018 - 2030 (USD Million)
Fig. 60 Malaysia market, 2018 - 2030 (USD Million)
Fig. 61 Singapore market, 2018 - 2030 (USD Million)
Fig. 62 Thailand market, 2018 - 2030 (USD Million)
Fig. 63 Taiwan market, 2018 - 2030 (USD Million)
Fig. 64 Latin America market, 2018 - 2030 (USD Million)
Fig. 65 Brazil market, 2018 - 2030 (USD Million)
Fig. 66 Mexico market, 2021 - 2030 (USD Million)
Fig. 67 Argentina market, 2018 - 2030 (USD Million)
Fig. 68 Colombia market, 2018 - 2030 (USD Million)
Fig. 69 Chile market, 2018 - 2030 (USD Million)
Fig. 70 MEA market, 2018 - 2030 (USD Million)
Fig. 71 South Africa market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 73 UAE market, 2018 - 2030 (USD Million)
Fig. 74 Egypt market, 2018 - 2030 (USD Million)
Fig. 75 Israel market, 2018 - 2030 (USD Million)
